WG
ARRY

Winton Group’s Array Biopharma Inc ARRY Stock Holding History

Winton Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,394
Closed -$205K – 1355
2019
Q1 		$205K Sell
8,394
-7,062
-46% -$147K ﹤0.01% 962
2018
Q4 		$220K Sell
15,456
-11,433
-43% -$173K ﹤0.01% 776
2018
Q3 		$409K Buy
26,889
+5,385
+25% +$82.5K 0.01% 706
2018
Q2 		$361K Sell
21,504
-5,966
-22% -$94.9K 0.01% 757
2018
Q1 		$448K Buy
+27,470
New +$440K 0.01% 826

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Winton Group's ARRY Position: Q2 2019 in Review

Winton Group sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 8,394 shares — an estimated $205K sold.

Winton Group first reported a position in ARRY in Q1 2018 and held it in 5 quarters. The position peaked at $448K in Q1 2018. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Winton Group reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Winton Group sold 8,394 Array Biopharma Inc shares in Q2 2019, an estimated $205K.
  • Winton Group first reported a position in Array Biopharma Inc in Q1 2018 and held it in 5 quarters.
  • Winton Group's Array Biopharma Inc position peaked at $448K in Q1 2018.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Winton Group's 13F filing for Q2 2019, filed 8 Jul 2019.